GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ha Noi CPC1 Pharmaceutical JSC (HSTC:DTP) » Definitions » Debt-to-Revenue

Ha Noi CPC1 Pharmaceutical JSC (HSTC:DTP) Debt-to-Revenue : 0.00 (As of . 20)


View and export this data going back to 2020. Start your Free Trial

What is Ha Noi CPC1 Pharmaceutical JSC Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Ha Noi CPC1 Pharmaceutical JSC's Short-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was ₫0.00 Mil. Ha Noi CPC1 Pharmaceutical JSC's Long-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was ₫0.00 Mil. Ha Noi CPC1 Pharmaceutical JSC's annualized Revenue for the quarter that ended in . 20 was ₫0.00 Mil.


Ha Noi CPC1 Pharmaceutical JSC Debt-to-Revenue Historical Data

The historical data trend for Ha Noi CPC1 Pharmaceutical JSC's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ha Noi CPC1 Pharmaceutical JSC Debt-to-Revenue Chart

Ha Noi CPC1 Pharmaceutical JSC Annual Data
Trend
Debt-to-Revenue

Ha Noi CPC1 Pharmaceutical JSC Semi-Annual Data
Debt-to-Revenue

Competitive Comparison of Ha Noi CPC1 Pharmaceutical JSC's Debt-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Ha Noi CPC1 Pharmaceutical JSC's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ha Noi CPC1 Pharmaceutical JSC's Debt-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ha Noi CPC1 Pharmaceutical JSC's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Ha Noi CPC1 Pharmaceutical JSC's Debt-to-Revenue falls into.



Ha Noi CPC1 Pharmaceutical JSC Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Ha Noi CPC1 Pharmaceutical JSC's Debt-to-Revenue for the fiscal year that ended in . 20 is calculated as

Ha Noi CPC1 Pharmaceutical JSC's annualized Debt-to-Revenue for the quarter that ended in . 20 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is one times the quarterly (. 20) Revenue data.


Ha Noi CPC1 Pharmaceutical JSC Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Ha Noi CPC1 Pharmaceutical JSC's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Ha Noi CPC1 Pharmaceutical JSC Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Ha Binh Phuong Industrial Cluster, Van Binh Commune, Thuong Tin District, Hanoi, VNM
Ha Noi CPC1 Pharmaceutical JSC is an investment holding company. The company's business activities include the Manufacture of cosmetics, soaps, detergents, polishes, and sanitary preparations; Producing drugs, pharmaceutical chemicals, and pharmaceutical materials; Manufacturing functional, nutritional, and health care foods, and Research and development of natural and academic sciences.